Avidity biosciences to participate in upcoming investor conferences

San diego , feb. 27, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating at the following upcoming conferences: td cowen 44th annual health care conference on march 5 at 10:30 a.m. pt/1:30 p.m.
RNA Ratings Summary
RNA Quant Ranking